Coinbase has added Bio Protocol (BIO) and Euler (EUL) to its asset listing roadmap, triggering immediate price rallies for both tokens. BIO surged from $0.0612 to $0.0733, marking an 18.99% gain, before retracing to stabilize at higher levels.
Similarly, EUL experienced a sharp increase, rising 22.22% from $13.51 to $16.50, then retracing to approximately $13.52 as initial volatility eased. This follows a historical pattern observed with other assets like ResearchCoin (RSC), which surged 82% after being included on Coinbase’s roadmap.
Separately, Bithumb’s listing of Chainbase (C) led to a significant price spike, climbing 26.03% from $0.365 to $0.465. The token later stabilized at $0.404, retaining an 11.3% gain from pre-listing levels.
Exchange listings often drive short-term volatility through heightened investor interest and speculative trading, resulting in initial price surges followed by stabilization or partial retracements, as seen in these cases.